Project Grant HT94252310823
Award Date
8/1/23
Completion Date
7/31/26
Dollars Obligated
$1.2M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Winston-Salem, NC 27157, USA
Similar Awards
This $653,317 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports the development of a novel graft-localized drug delivery platform at Wake Forest University Health Sciences (WFUHS). The funding will be used to conduct research aimed at attenuating innate inflammation and optimizing immunosuppression in vascularized composite allotransplantation over a 2-year period from September 2024 to September 2026. WFUHS, a leading...
This federal Project Grant award of $799,999.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports the "RESUSCITATION BY ENDOTHELIAL STABILIZATION AND TARGETED OXYGEN RESCUE (RESTOR) PLATFORM FOR VASCULARIZED COMPOSITE ALLOTRANSPLANTATION" research project at Wake Forest University Health Sciences (WFUHS), a leading academic medical center and research institution. The goal of this project is to...
The U.S. Department of the Army Medical Command has awarded a $2,469,162 Military Medical Research and Development (CFDA 12.420) Project Grant to Wake Forest University Health Sciences (WFUHS) to support research aimed at improving timely return to duty following nonunion. The research, which will take place in Winston-Salem, NC, is scheduled to be completed by September 29, 2029. This federal grant award is part of the Military Medical Research and Development program, which funds advanced...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $2,477,108 to Wake Forest University Health Sciences to conduct research on single-implant versus dual-implant fixation of distal femur extra-articular and complete articular fractures. The project will run from September 30, 2023 through September 29, 2027. Wake Forest University Health Sciences, an academic medical center, will lead this research...
This $299,999 Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports research conducted by Wake Forest University Health Sciences (WFUHS) to develop microparticle delivery of chemokine muteins for guiding chemokine receptor engineered regulatory T cells (Tregs) to induce tolerance after vascular composite allograft transplants. The research project aims to advance therapeutic...
Wake Forest University Health Sciences was awarded a $2,486,254 project grant from the Defense Health Agency to conduct a randomized clinical trial evaluating primary subtalar arthrodesis for calcaneal fractures. The grant is funded through the Military Medical Research and Development program, which supports biomedical research to improve health care for service members and the public through innovative solutions for battlefield medicine. Over a four-year period ending September 2027, Wake...
The Defense Health Agency awarded a $899,999 Project Grant to Wake Forest University Health Sciences under the Military Medical Research and Development program (CFDA 12.420) to develop a novel point-of-care assay for monitoring rejection and immunosuppression in vascularized composite allotransplantation (VCA) recipients. The project aims to transform healthcare for service members and the public through innovative biomedical research focused on medical solutions for the battlefield. The...
This $775,000 Project Grant from the Defense Health Agency under the CFDA 12.420 Military Medical Research and Development program supports research at Wake Forest University Health Sciences (WFUHS) to model airborne hazard exposures using an airway-on-a-chip platform. The goal is to elucidate common pathophysiological mechanisms and identify potential medical countermeasure targets. This 3-year research project, starting on September 1, 2023, will leverage WFUHS's expertise in biomedical...
The U.S. Defense Health Agency awarded a $1,965,204 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the University of Washington to support the early-stage development of an anti-inflammatory melanocortin fusion protein for tactical combat casualty care. The award period runs from August 1, 2024 to July 31, 2027. This research aims to investigate new therapeutic approaches for improving health outcomes for military service members. As a prominent...
This $1,535,039 federal Project Grant award from the Defense Health Agency's Military Medical Research and Development Program (CFDA 12.420) supports research conducted by Wake Forest University Health Sciences (WFUHS) to study how the breast tissue microbiota regulates immune checkpoint blockade therapy responsiveness in triple-negative breast cancer. The research aims to advance scientific understanding and develop new treatment approaches for this aggressive form of breast cancer that...